Phthalic Acid

Phthalic Acid

SCHEMBL49301

O=C([O-])c1ccccc1C(=O)[O-].[H+].[H+]

nearest known ligand 0.64

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.64
KDM4E B2RXH2 4/20 0.64
HPGD P15428 3/20 0.64
CA2 P00918 2/20 0.50
CA4 P22748 2/20 0.50
ALOX15 P16050 2/20 0.50
NFKB1 P19838 1/20 0.43
MAPK1 P28482 1/20 0.43
CYP2C19 P33261 1/20 0.43
BLM P54132 1/20 0.43
CES2 O00748 3/20 0.42
CES1 P23141 3/20 0.42
CA12 O43570 1/20 0.42
CA1 P00915 1/20 0.42
HMGB1 P09429 1/20 0.42
CA6 P23280 1/20 0.42
CA7 P43166 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
CA9 Q16790 1/20 0.42
NAPRT Q6XQN6 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phthalic Acid SCHEMBL8206690 1.00 ALDH1A1 (0.64) ALDH1A1KDM4EHPGDCA2CA4
Phthalic Acid SCHEMBL11216044 0.97 ALDH1A1 (0.61) ALDH1A1KDM4EHPGDCA2CA4
Phthalic Acid SCHEMBL11703255 0.97 ALDH1A1 (0.61) ALDH1A1KDM4EHPGDCA2CA4
Phthalic Acid SCHEMBL486782 0.97 ALDH1A1 (0.61) ALDH1A1KDM4EHPGDCA2CA4
Phthalic Acid SCHEMBL183233 0.97 ALDH1A1 (0.61) ALDH1A1KDM4EHPGDCA2CA4
Phthalic Acid SCHEMBL1156899 0.97 ALDH1A1 (0.61) ALDH1A1KDM4EHPGDCA2CA4
Phthalic Acid SCHEMBL2378712 0.97 ALDH1A1 (0.61) ALDH1A1KDM4EHPGDCA2CA4
Phthalic Acid SCHEMBL192152 0.97 ALDH1A1 (0.68) ALDH1A1KDM4EHPGDCA2CA4
Phthalic Acid SCHEMBL1157122 0.97 ALDH1A1 (0.61) ALDH1A1KDM4EHPGDCA2CA4
Phthalic Acid SCHEMBL7871837 0.97 ALDH1A1 (0.61) ALDH1A1KDM4EHPGDCA2CA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1831 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260094746-A1 Magnetorheological Fluid And Braking Device SEIKO EPSON CORP (JP) 2026-04-02 US claimed
US-12582629-B1 Extended-release pharmaceutical compositions of Ralinepag INNOVATE THERAPEUTICS LLC (US) 2026-03-24 US claimed
US-20250213601-A1 METHODS AND BIOAVAILABLE HIGHLY PERMEABLE COMPOUNDS FOR THE TREATMENT OF VIRAL DISEASES Didenko, Kirill (US) 2025-07-03 US claimed
CN-119875416-A Antistatic back coating, thermal transfer carbon ribbon and preparation method thereof 湖南鼎一致远科技发展股份有限公司 2025-04-25 CN claimed
CN-119186638-A Catalyst for preparing dialkyl carbonate, preparation method and application thereof 中国石油化工股份有限公司 2024-12-27 CN claimed
WO-2024189607-A1 METHODS AND BIOAVAILABLE HIGHLY PERMEABLE COMPOUNDS FOR DISEASES TREATMENT DIDENKO KIRILL (MX) 2024-09-19 WO claimed
CN-118495599-A Reticular structure ferric sulfide nano material and preparation method and application thereof 徐州医科大学 2024-08-16 CN claimed
CN-118191219-A Chemical quantitative tracking analysis method for macromolecular organic amine epoxy hardener synthesis process 绿健体育科技(山西)股份有限公司 2024-06-14 CN claimed
CN-118108554-A Reducing agent for preparing firework propellant 万载县建坤化工有限公司 2024-05-31 CN claimed
CN-118109946-A Photocatalyst composite antibacterial fabric and preparation method thereof 罗莱生活科技股份有限公司 2024-05-31 CN claimed
US-5527655-A FOR COATING LITHOGRAPHIC PLATES; QUATERNARY AMMONIUM AND PHOSPHONIUM SALTS MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1996-06-18 US claimed
US-5500668-A INK JET PRINTING XEROX CORPORATION (US) 1996-03-19 US claimed
EP-0653935-A4 PELLETISED PHARMACEUTICAL COMPOSITION. 1995-06-07 EP claimed
EP-0653935-A1 PELLETISED PHARMACEUTICAL COMPOSITION F.H. FAULDING & CO. LIMITED (AU) 1995-05-24 EP claimed
WO-1994003160-A1 PELLETISED PHARMACEUTICAL COMPOSITION F.H. FAULDING & CO. LIMITED (AU) 1994-02-17 WO claimed
EP-0228105-B1 PARTICLES CONTAINING DIHALOHYDANTOIN BLEACH IN A DILUTED CORE UNILEVER N.V. (NL) 1990-09-19 EP claimed
US-4777112-A THE POLYETHER HYDROGEN-BONDED TO ANOTHER POLYMER AND SALT OF POLYVINYLHYDROGEN PHTHALATE POLAROID CORPORATION (US) 1988-10-11 US claimed
EP-0228105-A2 Particles containing dihalohydantoin bleach in a diluted core UNILEVER N.V. (NL) 1987-07-08 EP claimed
US-4268694-A HYDROLYSIS OF TETRAHALOCYCLOHEXANONE FISONS LIMITED (GB) 1981-05-19 US claimed
US-4104072-A Water developable lithographic printing plate having dual photosensitive layering POLYCHROME CORPORATION (US) 1978-08-01 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260094746-A1 Magnetorheological Fluid And Braking Device BAP1, PBRM1, PAX3 ALDH1A1 4495/4885KDM4E 1288/4885HPGD 4654/4885
US-20250213601-A1 METHODS AND BIOAVAILABLE HIGHLY PERMEABLE COMPOUNDS FOR THE TREATMENT OF VIRAL DISEASES ACE2, FURIN, SARS1 ALDH1A1 2943/4885KDM4E 2815/4885HPGD 2020/4885
US-12582629-B1 Extended-release pharmaceutical compositions of Ralinepag RALA, ADH1A, PDE9A ALDH1A1 393/4885KDM4E 1365/4885HPGD 689/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.